hepatitis C

Achillion Pharmaceuticals (ACHN): A Potential Acquisition Target For Gilead Sciences (GILD)
Bidness Etc.
Tue, 11/11/14 - 10:32 am
Achillion
M&A
Gilead Sciences
hepatitis C
AbbVie Hepatitis C Drug Cures 97% in Transplant Patients Study
Bloomberg
Tue, 11/11/14 - 09:55 am
AbbVie
hepatitis C
ombitasvir
ritonavir
dasabuvir
ABT-450
Achillion Pharma rises on results from study combining hepatitis C drugs ACH-3102 and Sovaldi
Yahoo/AP
Mon, 11/10/14 - 03:55 pm
Achillion
ACH-3102
hepatitis C
Sovaldi
Merck’s Four-Week Hepatitis C Regimen Fails to Top Gilead
Bloomberg
Mon, 11/10/14 - 07:57 am
hepatitis C
Merck
Gilead Sciences
grazoprevir
elbasvir
Sovaldi
ALLY Trial Demonstrates High Cure Rates for Investigational Daclatasvir and Sofosbuvir Combination among Genotype 3 Hepatitis C Patients
Yahoo/BusinessWire
Sat, 11/8/14 - 11:35 am
daclatasvir
sofosbuvir
hepatitis C
hepatitis
Bristol-Myers Squibb
Achillion Reports 100% SVR12 in a Phase 2 Combination Study With ACH-3102 at the Liver Meeting 2014 (AASLD)
Yahoo/Globe NewsWire
Sat, 11/8/14 - 10:39 am
Achillion
ACH-3102
ACH-3422
HCV
hepatitis C
Biotech stocks to watch ahead of liver disease conference
CNBC
Fri, 11/7/14 - 03:54 pm
liver disease
Gilead Sciences
Intercept Pharma
Genfit
Merck
Achillion
AbbVie
NASH
hepatitis B
hepatitis C
Gilead Sciences: Another Big Jump in Hep-C Prescriptions
Barron's
Fri, 11/7/14 - 10:30 am
Gilead Sciences
hepatitis C
Sovaldi
Harvoni
Why AbbVie Inc.'s Game-Changing New Drug Could Be a Serious Threat to Gilead Sciences Inc.
Motley Fool
Fri, 11/7/14 - 10:11 am
AbbVie
Gilead Sciences
Enanta
Harvoni
hepatitis C
J&J Wins U.S. Approval for Hepatitis C Combo With Gilead
Bloomberg
Wed, 11/5/14 - 07:38 pm
JNJ
FDA
Gilead Sciences
hepatitis C
Olysio
GSK hepatitis C shot shows promise, bodes well for Ebola vaccines
Yahoo/Reuters
Wed, 11/5/14 - 07:33 pm
GSK
vaccines
ebola virus
hepatitis C
Bristol-Myers Plan to Widen Access to its Hep C Drug is Criticized
WSJ Pharmalot
Mon, 11/3/14 - 03:40 pm
Bristol-Myers Squibb
hepatitis C
Daklinza
daclatasvir
Gilead Sciences: Harvoni Still Selling Like Hotcakes
Barron's
Fri, 10/31/14 - 02:14 pm
Gilead Sciences
hepatitis C
Harvoni
Locking up Savings? Sovaldi Could be Cost Effective for Prisons: Study
WSJ Pharmalot
Tue, 10/28/14 - 10:32 am
Gilead Sciences
hepatitis C
Sovaldi
prisons
If It’s Bad For Merck, It’s Good For Gilead
Barron's
Mon, 10/27/14 - 03:25 pm
Merck
Gilead Sciences
hepatitis C
Sovaldi
JNJ
Olysio
Regulus Therapeutics more than doubles on early data for microRNA treatment for hepatitis C
Yahoo/AP
Wed, 10/22/14 - 07:05 pm
Regulus
hepatitis C
microRNA
RG-101
What Johnson & Johnson Can Tell Us about Gilead Sciences, inc. Stock
Motley Fool
Mon, 10/20/14 - 08:30 am
JNJ
Gilead Sciences
Olysio
hepatitis C
Sovaldi
This Drug Could Outsell Medical Marijuana
Motley Fool
Sun, 10/19/14 - 12:36 pm
Gilead
Harvoni
Sovaldi
hepatitis C
Medical Marijuana
Gilead's Harvoni Receives Notice of Compliance from Canada
Yahoo/Zacks.com
Fri, 10/17/14 - 07:08 pm
Gilead Sciences
Harvoni
hepatitis C
Canada
Should Gilead Sciences, inc. Fear Incoming Competition?
Motley Fool
Wed, 10/15/14 - 02:51 pm
Gilead Sciences
hepatitis C
AbbVie
Bristol-Myers Squibb

Pages